Building a biologicals business that lasts.
01
A discovery engine.
APEXbio™ finds and develops microbial products across biostimulants, biofungicides and bioinsecticides.
02
Products with growers.
ACTIV and INITIA are already in the field. VIRTUOSA® and VALORIA™ are in registration with the US EPA.
03
Partners with reach.
A strategic research partnership with Bayer and a commercial collaboration with Syngenta for ACTIV.
MILESTONES01 / PROGRESS
From spin-off to launch.
2017
Founded as a VIB spin-off · Series A €7.7 million
2020
Series B €19.8 million
2023
Series C €70 million · ACTIV launched · B Corp certified
2024
EPA dossier for VIRTUOSA® submitted
2025
Regulatory dossier for VIRTUOSA® submitted in the US and EU · Silver medal in first EcoVadis assessment
2026
Research partnership with Bayer on bioinsecticides
2027
VIRTUOSA® US launch, planned
BOARD OF DIRECTORS02 / GOVERNANCE
Board of directors.
Industry leaders from crop protection and the investors who back our science. Select a card for the full profile.
Hartmut van Lengerich
INDEPENDENT CHAIRMAN
Former CEO of Bayer Crop Science Canada and head of fungicides
Isabel Vercauteren
CEO & CO-FOUNDER
Plant biotechnologist, formerly R&D and licensing at Bayer CropScience
Caaj Greebe
INNOVATION INDUSTRIES
Partner at a European deep-tech venture fund
David Devigne
KORYS
Venture investor in life sciences
Barbara Berckmans
AIF
Investment manager, Agri Investment Fund of Boerenbond
Stéphane Roussel
ECBF
Partner, European Circular Bioeconomy Fund
Hendrik Van Asbroek
ASTANOR
Partner at Astanor, food and agriculture impact investor
BOARD OBSERVERS03 / OBSERVERS
Willem Broekaert
V-BIO VENTURES
Antonio Garcia Maldonado
GATES FOUNDATION
Lakshmi Manavalan
GATES FOUNDATION
Peter De Decker
SFPI-FPIM
In memory of Johan Cardoen
VIB · † 17 DECEMBER 2025
OUR INVESTORS04 / BACKED BY
Backed by investors in science and impact.
V-Bio Ventures
Astanor
ECBF
AIF
PMV
VIVES
Qbic
VIB
KU Leuven
Van den Venne
Group DC
SFPI-FPIM
Gates Foundation
Korys
Innovation Industries
Fortis
IN THE PRESS05 / COVERAGE
SIFTED
Aphea.Bio raises a €70m Series C for pesticide alternatives
NEW AG INTERNATIONAL
Aphea.Bio submits VIRTUOSA® and VALORIA™ to the US EPA
APHEA.BIO NEWS
Strategic research partnership with Bayer on bioinsecticides
Talk to us about investing.
Investor enquiries go directly to our leadership team.